Tag: IBS
April 17, 2018
Biomerica Announces Third Quarter Financial Results
Biomerica (Nasdaq:BMRA) today reported net sales of $4,433,785 for the nine months ending February 28, 2018, compared to $4,342,247 for... March 19, 2018
Knight Announces Exclusive License Agreement with Ardelyx for Tenapanor
Knight Therapeutics (TSX:GUD) announced today a license agreement with Ardelyx (NASDAQ:ARDX) that provides Knight with exclusive rights to commercialize tenapanor...
October 18, 2017
Focus Graphite Unveils Its Highly Conductive Ultrafine and Expanded Graphites For Battery Cathodes
Focus Graphite Unveils Its Highly Conductive Ultrafine and Expanded Graphites For Battery Cathodes Creating a Complete Line of Value-Added Lac...
October 10, 2017
Focus Graphite Introduces Its New “Superfine Grade” of Coated Spherical Graphite for Lithium Batteries to the International Battery Industry
Focus Graphite Inc. (TSXV:FMS,OTCQX:FCSMF,FWB:FKC) is pleased to announce the introduction of a Superfine Grade of coated spherical graphite product sourced from... August 30, 2017
Biomerica Announces Fiscal Year End 2017 Financial Results
Biomerica released their financial results for their fiscal 2017 year. June 21, 2017
AXIM Biotech Secures Funding for Trials and Studies
AXIM Biotechnologies secured funding to continue its trials and cannabinoid research. April 13, 2017